EMvision Medical Devices (ASX:EMV) Issuance of Debt: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EMV EMvision Medical Devices Ltd ASX:EMV
20 GF Score
Price A$1.54
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Issuance of Debt?

EMvision Medical Devices ASX:EMV -5.23% 20 Issuance of Debt is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's Issuance of Debt for the six months ended in Dec. 2025 was A$0.00 Mil.

EMvision Medical Devices's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

EMvision Medical Devices Issuance of Debt Related Terms

EMvision Medical Devices Issuance of Debt Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Issuance of Debt Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Issuance of Debt
Get a 7-Day Free Trial 0.00 0.00 2.75 0.00 0.00

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:EMV
20GF Score
EMvision Medical Devices Ltd ASX:EMV
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of A$0.00 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Issuance of Debt of A$0.00 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on EMvision Medical Devices and its competitors.
Is EMvision Medical Devices' Issuance of Debt too high?
EMvision Medical Devices' current Issuance of Debt is A$0.00 Mil. Overall, EMvision Medical Devices has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Issuance of Debt compare to ABT and SYK?
EMvision Medical Devices' Issuance of Debt of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on EMvision Medical Devices and its competitors. EMvision Medical Devices's current Issuance of Debt is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Issuance of Debt of A$0.00 Mil. The current Issuance of Debt is A$0.00 Mil. EMvision Medical Devices' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Issuance of Debt is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
20GF Score

Get the complete analysis for ASX:EMV

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.54
Price